Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesMalignant neoplasms of respiratory and intrathoracic organsICD-10-CM c31-malignant-neoplasm-accessory-sinuses
    Ask Trek AI about this page

    ICD-10-CM Code For Malignant Neoplasm Of Accessory Sinuses: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group C31 includes malignant neoplasms of the accessory sinuses, covering cancers of the maxillary, ethmoid, frontal, and sphenoid sinuses and related sinus sites. These ICD-10-CM diagnosis codes are used to document clinical encounters involving primary malignant sinus tumors, capturing site, laterality, and extent of local invasion or metastasis. Accurate coding within the ICD-10-CM C31 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Malignant Neoplasm Of Accessory Sinuses: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM C31: Malignant Neoplasm Of Accessory Sinuses Overview

    This group represents malignant tumors arising in the accessory sinuses, including the maxillary, ethmoid, frontal, and sphenoid sinuses that support the nasal cavity. These cancers affect the upper respiratory tract and adjacent head and neck structures and often require detailed clinical documentation of site, laterality, and extent. Accurate coding matters for reimbursement because claims processing and severity assignment depend on precise site and histology information.

    Table of contents

    Progress1 / 5

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when a clinical diagnosis identifies a primary malignant neoplasm of an accessory sinus and documentation specifies the site or laterality. Assign the most specific code available to reflect tumor location, local extension, and any documented metastasis.

    ICD-10-CM Codes

    6 rows

    ICD-10-CM CodeDescription
    C31.0Malignant neoplasm of maxillary sinus
    C31.1Malignant neoplasm of ethmoidal sinus
    C31.2Malignant neoplasm of frontal sinus
    C31.3Malignant neoplasm of sphenoid sinus
    C31.8Malignant neoplasm of overlapping sites of accessory sinuses
    C31.9Malignant neoplasm of accessory sinus, unspecified

    DRG Codes

    6 rows

    DRG CodeDescription
    011Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with MCC
    012Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with CC
    013Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy without CC/MCC
    146Ear, Nose, Mouth and Throat Malignancy with MCC
    147Ear, Nose, Mouth and Throat Malignancy with CC
    148Ear, Nose, Mouth and Throat Malignancy without CC/MCC

    Related Codes

    C30-MALIGNANT-NEOPLASM-NASAL-CAVITY-MIDDLE-EAR

    ICD-10-CM Code For Malignant Neoplasm Of Nasal Cavity And Middle Ear: Group Overview

    C32-MALIGNANT-NEOPLASM-OF-LARYNX

    ICD-10-CM Code For Malignant Neoplasm Of Larynx: Group Overview

    C33-MALIGNANT-NEOPLASM-OF-TRACHEA

    ICD-10-CM Code For Malignant Neoplasm Of Trachea: Group Overview

    C34-MALIGNANT-NEOPLASM-OF-BRONCHUS-AND-LUNG

    ICD-10-CM Code For Malignant Neoplasm Of Bronchus And Lung: Group Overview

    C37-MALIGNANT-NEOPLASM-OF-THYMUS

    ICD-10-CM Code For Malignant Neoplasm Of Thymus: Group Overview

    C38-MALIGNANT-NEOPLASM-HEART-MEDIASTINUM-PLEURA

    ICD-10-CM Code For Malignant Neoplasm Of Heart Mediastinum And Pleura: Group Overview

    C39-MALIGNANT-NEOPLASM-OTHER-ILL-DEFINED-SITES

    ICD-10-CM Code For Malignant Neoplasm Of Other And Ill-Defined Sites In The Respiratory System And Intrathoracic Organs: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.